Privo Technologies Inc Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Privo Technologies Inc is a privately funded biotechnology firm focused on cancer therapy and drug delivery. Based in Peabody, Massachusetts, the company develops a mucosal delivery platform designed to provide constant, controlled therapeutic dosing through mucosal surfaces, enabling local and systemic delivery without needles and with the aim of reducing drug-related toxicity while enabling higher, more effective dosing. The approach targets oncology applications and has potential applicability to both small and large molecules, with ongoing work rooted in the legacy of the Langer Laboratory at MIT and advisory input from Professor Robert Langer. Privo positions itself within the biotechnology research industry as a Phase III oncology company pursuing next-generation delivery methods to improve patient outcomes and treatment adherence. Notable recent developments include the launch of a subsidiary focused on companion animal oncology and other publicized milestones related to clinical progress and recognition, reflecting activity beyond its initial research and development efforts.

Get verified Privo Technologies Inc emails free

Company overview Employee directory